Device / Technology News

RSS

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012

USPTO issues patent to Aeterna Zentaris’ AEZS-130 oral test for AGHD

Aeterna Zentaris Inc. today announced that the United States Patent and Trademark Office has granted a patent for the use of its oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency.

7 Aug 2012

Applied BioCode receives U.S. patent for ‘Light Transmitted Assay Beads’

Applied BioCode, Inc. today announced that the United Stated Patent and Trademark Office has granted US Patent #8,232,092 "Light Transmitted Assay Beads," describing the method of decoding barcodes and analyzing bioassays using Barcoded Magnetic Beads (BMB) multiplex products.

7 Aug 2012

Study suggests race-specific cutoff points for a diabetes diagnostic test

Healthcare providers should take into account differences among racial groups when using hemoglobin A1C levels to diagnose and monitor diabetes, new research from Beth Israel Deaconess Medical Center suggests.

7 Aug 2012

New Cornell study: Eyes reveal sexual orientation

There is a popular belief that sexual orientation can be revealed by pupil dilation to attractive people, yet until now there was no scientific evidence. For the first time, researchers at Cornell University used a specialized infrared lens to measure pupillary changes to participants watching erotic videos. Pupils were highly telling: they widened most to videos of people who participants found attractive, thereby revealing where they were on the sexual spectrum from heterosexual to homosexual.

7 Aug 2012

FDA clears Toshiba’s new 16-element flexible coil system

To improve MR exam efficiency and image quality, Toshiba America Medical Systems, Inc. has received FDA clearance for its high-density 16-element flexible coil system, developed in partnership with NeoCoil. The new coil system makes it easier for clinicians to complete high-quality exams and improve diagnostic efficiency.

7 Aug 2012

ONR develops Protections in Research, Oversight Management Information System

A Web-based application developed by the Office of Naval Research (ONR) will form the basis of the nation's first Defense Department-wide system to track and manage human subject studies funded by the federal government, officials announced Aug. 6.

7 Aug 2012

UV dosimeter technology helps prevent over-exposure to the sun

A monitor developed at the University of Strathclyde in Glasgow, Scotland, to help prevent over-exposure to the sun is set to go on the market as part of a new spinout company.

7 Aug 2012

Link between cardiac catheterizations and risk of stroke

When a patient undergoes a cardiac catheterization procedure such as a balloon angioplasty, there's a slight risk of a stroke or other neurological complication.

7 Aug 2012

Wellcome Trust grants £1.6 million Translation Award for development of more effective radiotherapy

The Wellcome Trust has awarded a £1.6 million Translation Award to a research team led by the University of Lincoln to develop more effective radiotherapy treatment for thousands of cancer sufferers by providing unique monitoring and imaging for patients receiving proton therapy.

6 Aug 2012

Empa physicist analyzes structure and composition of soot particles

Since June 2012, it is official: The World Health Organisation (WHO) has classified diesel soot as a lung carcinogen. Artur Braun, a physicist at Empa and an X-ray spectroscopy expert, has made crucial contributions to analyzing the structure and composition of soot particles.

6 Aug 2012

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

Bausch + Lomb, the global eye health company, and Technolas Perfect Vision GmbH, a leading ophthalmology laser company, announced today that the VICTUS Femtosecond Laser Platform received 510(k) clearance from the U.S. Food and Drug Administration.

6 Aug 2012

ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies

Accu-Break Pharmaceuticals, Inc. announced today that it has entered into a development and license agreement with Alembic Pharmaceuticals Limited of Gujarat, India to develop new brand products that will use ABP's innovative Accu-Break tablet technologies.

6 Aug 2012

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

About two years ago NeuroMetrix changed their focus from general purpose devices, used to perform nerve conduction tests, to devices designed to specifically address diabetic peripheral neuropathy or DPN.

6 Aug 2012

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).

6 Aug 2012

Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.

6 Aug 2012

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Foundation Medicine, Inc. and Clovis Oncology, Inc. announced today that they have entered into a diagnostic collaboration.

6 Aug 2012

Computerized brain fitness program improves memory and language skills in older adults

UCLA researchers found that older adults who regularly used a brain fitness program played on a computer demonstrated significantly improved memory and language skills.

6 Aug 2012

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Luminex Corporation announced today that Public Health Wales is using Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales. Results of a substantial diagnostic validation of the GPP test conducted by The Public Health Wales Microbiology laboratory team at the University Hospital of Wales, Cardiff, are anticipated to be published in a peer reviewed journal

From Luminex 6 Aug 2012

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.

6 Aug 2012

Device / Technology News

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

USPTO issues patent to Aeterna Zentaris’ AEZS-130 oral test for AGHD

Applied BioCode receives U.S. patent for ‘Light Transmitted Assay Beads’

Study suggests race-specific cutoff points for a diabetes diagnostic test

New Cornell study: Eyes reveal sexual orientation

FDA clears Toshiba’s new 16-element flexible coil system

ONR develops Protections in Research, Oversight Management Information System

UV dosimeter technology helps prevent over-exposure to the sun

Link between cardiac catheterizations and risk of stroke

Wellcome Trust grants £1.6 million Translation Award for development of more effective radiotherapy

Empa physicist analyzes structure and composition of soot particles

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

ABP, Alembic enter into development and license agreement for Accu-Break tablet technologies

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Clovis Oncology, Foundation Medicine enter diagnostic collaboration

Computerized brain fitness program improves memory and language skills in older adults

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News